Exclusive weekly insights for sharemarket success.
Tim Lincoln, Co-Founder and Chief Investment Officer, and Matt Swartz, Senior Portfolio Manager, will join the conversation once a month to share their passion and strategy for Lincoln Indicator’s Managed Funds, as well as their insights for investors.
Kien Trinh (Head of Research) and Jacob Simonsen (Equities Analyst) review the Star stock performance for January and provide further reasons why they believe the sharemarket will continue to rise this year.
At the stock level, they speak to result updates from BWP Trust (BWP), ResMed Inc. (RMD) and Rhipe Limited (RHP), and put Borderline Star Growth addition, South32 Limited (S32) under the microscope.
To conclude, they provide clarity on when an investor should sell a stock following a company announcement.
We hope you find this video useful.
Experience Stock Doctor yourself by taking a FREE trial today.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.